Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
AIM: To evaluate the effectiveness of montelukast as add-on therapy for asthmatic patients who remain uncontrolled with low, moderate or high doses of inhaled corticosteroid monotherapy.
Saved in:
Main Authors: | J Mark FitzGerald, Sylvain Foucart, Stephen Coyle, John Sampalis, Denis Haine, Eliofotisti Psaradellis, R Andrew McIvor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2009/593753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01) -
Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial
by: R Andrew McIvor, et al.
Published: (2009-01-01) -
Inhaled Corticosteroid Therapy Does Not Control Asthma
by: Robert L Cowie, et al.
Published: (2004-01-01) -
Asthma Control in Canada Remains Suboptimal: The Reality of Asthma Control (TRAC) Study
by: J Mark FitzGerald, et al.
Published: (2006-01-01) -
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
by: Amir Hossein Alizadeh Bahmani, et al.
Published: (2025-01-01)